Search
Welcome
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
Not a subscriber? Subscribe here
Register Now
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
                       
Careers & Tenders
Newsletters
Subscribe
The Mail & Guardian
      SUBSCRIBE / Support independent journalism                   CAREERS & TENDERS / Visit careers.mg.co.za                   WHATSAPP? / Follow the M&G WhatsApp channel here            
Login / Register

LOGIN

  • News
    • Africa
    • Business
    • Editorial
    • Education
    • Health
    • Motoring
    • National
    • Sci-tech
    • Sport
    • World
  • Thought Leader
  • Politics
  • Green Guardian
  • Friday
  • Features
    • Buthelezi, the King’s Hand
    • Cabinet Report Cards 2023
    • Cabinet Report Cards 2012-2021
    • The Fiscal Cliff
  • Research World
    • Submissions
    • Papers
  • 200 Young South Africans
  • Events
    • 200 Young South Africans
    • Greening The Future
    • Power Of Women
      • 2024 Edition
    • Critical Thinking Forum
    • Youth Summit
    • Webinars
  • More..
    • Partners
    • Podcasts
    • Crossword
    • Digital Editions
    • Register
    • WhatsApp Channel
    • Login
    • Lost Password

           

Hiv Drugs

The Global Fund has just made history – now it must start a revolution
Thought Leader
/ 21 May 2025

The Global Fund has just made history – now it must start a revolution

Africa’s first locally made HIV treatment is more than a milestone, it’s a political, economic and moral turning point in the fight for health sovereignty

By Tian Johnson
A to Z guide on HIV: The top 10 things to know from prevention to a possible cure
Health
/ 1 December 2021

A to Z guide on HIV: The top 10 things to know from prevention to a possible cure

The HIV pandemic isn’t going anywhere until a cure is found. In the meantime, HIV clinicians say South Africa should protect its victories

By Nomathemba Chandiwana, Bronwyn Bosch, Simiso Sokhela and Francois Venter
Risks & benefits: new HIV drug combo could change the course of SA’s epidemic
Health
/ 6 December 2019

Risks & benefits: new HIV drug combo could change the course of SA’s epidemic

South Africa’s next chapter in HIV treatment holds amazing promise, but unlocking it rests on having the right kind of discussions with women

By Laura López González
#AIDS2016: ​HIV may be a prescribed benefit, but not all medical schemes cover ARVs
Article
/ 18 July 2016

#AIDS2016: ​HIV may be a prescribed benefit, but not all medical schemes cover ARVs

In theory medical aids fund ARVs, but in practice it’s a complex process, say doctors and activists.

By Laura Lopez Gonzalez
Activists lead fight for the right to cheaper drugs
Article
/ 7 April 2016

Activists lead fight for the right to cheaper drugs

There is a big move afoot to alert SADC members to the concessions on intellectual property rights that they can take advantage of.

By Amy Green
Sangomas learn to meld muti with conventional medicine
Article
/ 3 March 2016

Sangomas learn to meld muti with conventional medicine

Traditional and Western healers team up to treat patients with HIV and tuberculosis because many people consult more than one health system.

By Ina Skosana
No image available
Article
/ 18 December 2013

US health policy weighs on SA’s HIV patients

Hundreds of thousands of HIV patients could be affected by Pepfar’s shift in funding policy, according to a new report.

By Mara Kardas-Nelson
No image available
Article
/ 5 April 2013

State consolidates HIV treatment

New medicine combines ARVs into one pill, making them easier to supply.

By Mia Malan and Ina Skosana
Funding crisis looms large
Article
/ 28 March 2013

Funding crisis looms large

HIV counsellors play a vital role in Lesotho’s health system, but the money is running out.

By Staff Reporter
Women confound HIV researchers
Article
/ 8 March 2013

Women confound HIV researchers

Why would young, single African women not take free drugs that could potentially save them from contracting a life-threatening infection?

By Mia Malan
Cheap drugs a bitter pill for the West
Article
/ 8 March 2013

Cheap drugs a bitter pill for the West

A global squabble over property rights could see the price of medicine soar in poor countries.

By Mara Kardas-Nelson
Drop in infections follows ARVs’ success
Article
/ 21 February 2013

Drop in infections follows ARVs’ success

ARVs have slowed down the rate of new HIV infections and increased the life expectancy of the general population in rural KZN

By Staff Reporter
Aids takes heavier toll on men
Article
/ 26 October 2012

Aids takes heavier toll on men

A study published in the latest edition of a leading medical journal explains why the survival rate of HIV-positive women is higher than that of men.

By Mia Malan
Light shines at the end of the HIV tunnel
Article
/ 14 September 2012

Light shines at the end of the HIV tunnel

For the first time an Aids vaccine in our lifetime is possible, but scientists need money and support to make it work.

By Mitchell Warren
A pill a day could keep HIV away
Article
/ 17 August 2012

A pill a day could keep HIV away

A new report says men are able to plan their sex lives better than women and the day of the week on which the fewest people have sex is Tuesday.

By Mia Malan
Clash over HIV drug’s ‘success’
Article
/ 17 August 2012

Clash over HIV drug’s ‘success’

Pressure’s mounting on SA’s Medicines Control Council to register the use of Truvada by the HIV-negative to lower chances of being infected with HIV.

By Mia Malan
Domestic violence a driver of HIV
Article
/ 21 June 2012

Domestic violence a driver of HIV

Health professionals must note the link between women abuse and an increased risk of infection, writes Kate Joyner

By Kate Joyner
Jury out on using ARV prophylaxis
Article
/ 14 June 2012

Jury out on using ARV prophylaxis

South African clinicians have outlined best practice as use of the treatment to prevent infection increases, writes Mia Malan.

By Mia Malan
No image available
Article
/ 18 April 2011

Once-promising HIV drug trial called off

A large trial of the drug Truvada, hoped to be a successful HIV-preventing treatment for women, has been halted after it was found to be ineffective.

By Faranaaz Parker
No image available
Article
/ 3 February 2011

Researchers criticise Aids spending, stigma

Nearly three million lives have been saved by HIV/Aids treatment, according to a new book commissioned by the United Nations.

By Staff Reporter
No image available
Article
/ 24 November 2010

Daily pill helps prevent HIV infection in men

Campaigners say breakthrough with once-a-day pill could change approaches to preventing HIV and Aids.

By Staff Reporter
‘Glimmer’ of hope for Aids vaccine
Article
/ 24 April 2010

‘Glimmer’ of hope for Aids vaccine

A leader in the search for a vaccine against HIV said on Friday that recent advances have given scientists new reason for hope.

By Donna Bryson
No image available
Article
/ 6 November 2009

GSK drops drug prices for poor nations

The world’s second-biggest drug company is cutting its prices for some countries – but not for HIV patients, writes Qudsiya Karrim.

By Qudsiya Karrim
No image available
Article
/ 29 July 2009

Cash crisis hits Aids fund

The Global Fund to Fight Aids, Malaria and TB, the largest funder of Aids programmes worldwide, has an estimated shortfall of $3-billion to $5-billion

By Mara Kardas-Nelson
No image available
Article
/ 13 March 2009

Balfour ‘disappointed’ at prisoner report outcome

Ngconde Balfour is disappointed that a court bid to block the release of a report on the death of an HIV-positive prisoner was dismissed on Friday.

By Staff Reporter
No image available
Article
/ 5 March 2009

Out of stock = out of life

ARV shortages are compounded by the increase in people needing treatment.

By Nosimilo Ndlovu
No image available
Article
/ 3 July 2008

HIV — cheaper to treat

Individuals, companies and the economy are at risk if it is not dealt with effectively, argues Ian Sanne.

By Ian Sanne

MAIL & GUARDIAN

ABOUT

About
Contact
Advertise

SUBSCRIPTIONS

Subscribe
Newsletters

FOLLOW

WhatsApp Channel
Twitter
Facebook
YouTube
Instagram
LinkedIn
TikTok
Threads

FLAGSHIP EVENTS

200 Young South Africans
Power Of Women
Greening The Future

LEGAL & CORRECTIONS

Privacy Policy
Cookie Policy
Ethics & Social Media Policy

RESOURCES

Mail & Guardian Careers
Property for sale


Mail & Guardian

© 2025 The Mail & Guardian. All rights reserved.

  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }